Strategic oversight, commercial insight, and governance for a complex European landscape. 

​

At CSP, we recognise that many growing life-science organisations need more than operational expertise - they need experienced strategic direction to navigate European commercialisation, investment planning, and compliance. Through Non-Executive Director (NED) and Board Advisory roles, we provide that independent voice of experience, combining commercial acumen with a deep understanding of market access, early-stage growth, and stakeholder engagement across Europe. 

​

​

Our Experience

​

CSP's Non-Executive practice draws on decades of experience in European pharmaceutical commercialisation, rare-disease access, and strategic partnerships with both private and public sector stakeholders. Our approach is collaborative, transparent, and always centred on driving measurable outcomes for patients, investors, and stakeholders alike.​

​

 

​​Why Appoint a Non-Executive Director

 

An effective NED strengthens decision-making, protects governance integrity, and ensures alignment between clinical ambitions, investor expectations, and market realities. CSP brings a pragmatic, outcomes-focused approach that helps leadership teams anticipate challenges and seize opportunities early. ​

​​

​